A groundbreaking initiative emerging from the University of California, San Dieg...
Recent discussions surrounding children’s engagement with technology have pivote...
The latest Phase 3 trial results for Immunovant’s batoclimab drug showed achieve...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has introduced...
Sanofi will commence a Phase I/II trial with its vaccine candidate in the next f...
While Cassava is stopping investigations into simufilam in Alzheimer’s disease, ...
Character Biosciences has raised $93m in an oversubscribed Series B funding roun...
MSD has entered an exclusive licence agreement with Hengrui Pharma for the oral ...
MSD has received approval from the EC for Capvaxive, a pneumococcal 21-valent co...
EU member states are set to launch the EU Health Data Space Regulation for harmo...
Ensuring the highest standards in pharmaceutical logistics is crucial for patien...
The FDA has approved GSK’s Blujepa for treating uncomplicated urinary tract infe...
Multinational companies in China’s vaccine market face headwinds amid an anti-co...
People residing in neighborhoods characterized by significant socioeconomic disa...
In a groundbreaking manuscript published in the American Journal of Psychiatry, ...
Heart Health and Brain Volume: A Link to Cognitive Decline? Emerging research un...
